Más R. D-002: Beeswax alcohols. Drugs of the Future. 2001;26:731-744. Carbajal D, Molina V, Valdés S, Arruzazabala ML, Mas R. Anti-inflammatory activity of D-002: an active product isolated from beeswax. Prostagl Leukotr Essent Fatty Acids. 1998;59:235-238. Menéndez R, Amor AM, González RM, Jiménez S, Mas R. Inhibition of rat microsomal lipid peroxidation by the oral administration of D-002. Brazil J Med Biol Res. 2000;33:85-90. Pérez Y, González RM, Amor AM, Jiménez S., Menéndez R. D-002 on antioxidant enzymes in liver and brain of rats. Rev CENIC Cien Biol 2002;53(1):3-5. Carbajal D, Molina V, Valdés S, Arruzazabala ML, Mas R. Possible cytoprotective mechanism in rats of D-002 an anti-ulcerogenic product isolated from beeswax. J Pharm Pharmacol. 1996;48:858-860. Molina V, Valdés S, Carbajal D, Arruzazabala ML, Menéndez R, Mas R. Antioxidant effects of D-002 on gastric mucosa of rats with experimentally-induced injury. J Med Food. 2000;4(2):79-83. Hano O, Illnait J, Mas R, Fernández L, Piñol F, Fernández J. Effects of D-002, a product isolated from beeswax on duodenal ulcer: a double-blinded placebo-controlled study. Curr Ther Res. 2001;62:394-397. Terry H, Illnait J, Mas R, Fernández L, Carbajal D. Effects of D-002, a product isolated from beeswax, on gastric symptoms of patients with osteoarthritis treated with piroxicam: a pilot study. J Med Food. 2005;8(1):63-68. Menéndez R, Mas R, Amor AM, Pérez Y, González RM, Fernández JC, Molina V. Antioxidant effect of D-002 on in vitro susceptibility of whole plasma in healthy volunteers. Arch Med Res. 2001;32:436-441. Menéndez R, Mas R, Illnait J, Pérez Y, Amor AM, Fernández JC, González RM. Effects of D-002 on lipid peroxidation in older subjects. J Med Food. 2001;4(2):71-77. Illnait J, Rodríguez I, Molina V, Mas R, Fernández L, Fernández J. Effects of D-002 (beeswax alcohols) on gastrointestinal symptoms and oxidative markers in middle-aged and older subjects. Lat Am J Pharm. 2013;32(2):166-174. Illnait J, Rodríguez I, Mendoza S, Fernández J., Mas R. Effects of D-002, a mixture of high molecular weight beeswax alcohols, on patients with non-alcoholic fatty liver disease (NAFLD). KJIM. 2013;28(4):439-448.